Detalhe da pesquisa
1.
Natural Killer Cell Immunotherapy for Osteosarcoma.
Adv Exp Med Biol
; 1257: 141-154, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32483737
2.
Novel heterozygous mutation in the PTEN gene associated with ovarian germ cell tumor complicated by growing teratoma syndrome and overgrowth in a two-year-old female.
Pediatr Blood Cancer
; 66(8): e27788, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31038288
3.
Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies.
J Immunother Cancer
; 11(12)2023 12 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38081778
4.
CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy.
Front Oncol
; 12: 834002, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35449580
5.
Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future.
Stem Cell Res Ther
; 12(1): 211, 2021 03 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33766099
6.
COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients.
J Infect
; 82(3): 329-338, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33549624
7.
Therapeutic modulation of the CD47-SIRPα axis in the pediatric tumor microenvironment: working up an appetite.
Cancer Drug Resist
; 3(3): 550-562, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-35582455
8.
Genetic and epigenetic modification of human primary NK cells for enhanced antitumor activity.
Semin Hematol
; 57(4): 201-212, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33256913
9.
Hospital-to-Home Interventions, Use, and Satisfaction: A Meta-analysis.
Pediatrics
; 142(5)2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30352792